IGM Biosciences, Inc. Proceeds from Issuance Initial Public Offering
IGM Biosciences, Inc. reported Proceeds from Issuance Initial Public Offering of $187.16 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2021-03-30
- IGM Biosciences, Inc. proceeds from issuance initial public offering for the quarter ending 2019-12-31 was -$1.00K.
- IGM Biosciences, Inc. proceeds from issuance initial public offering for fiscal 2019 was $187.16M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $187.16M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $187.16M 10-Q · filed 2020-11-05 |